SILVER STD RES (SSRI) Downgraded by Zacks to OUTPERFORM

Zacks Investment Research downgraded shares of SILVER STD RES (SSRI) from N/A to OUTPERFORM on August 27, 2014, with a target price of $9.90.

Silver Standard is focused on the acquisition, exploration and development of silver-dominant projects. They have a quality portfolio of core properties in the development pipeline in Argentina, Mexico, Chile, the United States and Australia.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

To get a free copy of the research report on SILVER STD RES (SSRI),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .